Exact Mass: 463.1622

Exact Mass Matches: 463.1622

Found 126 metabolites which its exact mass value is equals to given mass value 463.1622, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Rosuvastatin 5 S-lactone

N-[4-(4-fluorophenyl)-5-[(E)-2-[(2S,4R)-4-hydroxy-6-oxooxan-2-yl]ethenyl]-6-(propan-2-yl)pyrimidin-2-yl]-N-methylmethanesulfonamide

C22H26FN3O5S (463.1577)

Rosuvastatin 5 S-lactone is a metabolite of rosuvastatin. Rosuvastatin (marketed by AstraZeneca as Crestor) is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It was developed by Shionogi. (Wikipedia)

ent-Rosuvastatin Lactone

N-[4-(4-Fluorophenyl)-5-[2-(4-hydroxy-6-oxooxan-2-yl)ethenyl]-6-(propan-2-yl)pyrimidin-2-yl]-N-methylmethanesulphonamide

C22H26FN3O5S (463.1577)

Sipoglitazar

3-[3-ethoxy-1-({4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl}methyl)-1H-pyrazol-4-yl]propanoic acid

C25H25N3O4S (463.1566)

C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist

dG-C8-IQ

C21H21N9O4 (463.1716)

consensus spectrum

mayamycin

C26H25NO7 (463.1631)

Thr Asp Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carboxypropanamido]-3-carbamoylpropanamido]butanedioic acid

C16H25N5O11 (463.155)

8-2-Amino-3-methylimidazo[4,5-f]quinoline-deoxyguanosine

C21H21N9O4 (463.1716)

Cys Met Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S2 (463.1559)

Cys Met Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C17H29N5O6S2 (463.1559)

Cys Asn Met Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S2 (463.1559)

Cys Asn Pro Met

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid

C17H29N5O6S2 (463.1559)

Cys Pro Met Asn

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]-3-carbamoylpropanoic acid

C17H29N5O6S2 (463.1559)

Cys Pro Asn Met

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-4-(methylsulfanyl)butanoic acid

C17H29N5O6S2 (463.1559)

Asp Asp Asn Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C16H25N5O11 (463.155)

Asp Asp Gln Ser

(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-3-{[(1S)-3-carbamoyl-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propyl]carbamoyl}propanoic acid

C16H25N5O11 (463.155)

Asp Asp Ser Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C16H25N5O11 (463.155)

Asp Asp Thr Asn

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C16H25N5O11 (463.155)

Asp Glu Asn Ser

(4S)-4-[(2S)-2-amino-3-carboxypropanamido]-4-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C16H25N5O11 (463.155)

Asp Glu Ser Asn

(4S)-4-[(2S)-2-amino-3-carboxypropanamido]-4-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}butanoic acid

C16H25N5O11 (463.155)

Asp Gly Ser Trp

(3S)-3-amino-3-[({[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C20H25N5O8 (463.1703)

Asp Gly Trp Ser

(3S)-3-amino-3-[({[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C20H25N5O8 (463.1703)

Asp Asn Asp Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-3-carboxypropanamido]-3-hydroxybutanoic acid

C16H25N5O11 (463.155)

Asp Asn Glu Ser

(4S)-4-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-4-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}butanoic acid

C16H25N5O11 (463.155)

Asp Asn Ser Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]pentanedioic acid

C16H25N5O11 (463.155)

Asp Asn Thr Asp

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]butanedioic acid

C16H25N5O11 (463.155)

Asp Gln Asp Ser

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carbamoylbutanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C16H25N5O11 (463.155)

Asp Gln Ser Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carbamoylbutanamido]-3-hydroxypropanamido]butanedioic acid

C16H25N5O11 (463.155)

Asp Ser Asp Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-3-carboxypropanamido]-4-carbamoylbutanoic acid

C16H25N5O11 (463.155)

Asp Ser Glu Asn

(4S)-4-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}butanoic acid

C16H25N5O11 (463.155)

Asp Ser Gly Trp

(3S)-3-amino-3-{[(1S)-1-[({[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]-2-hydroxyethyl]carbamoyl}propanoic acid

C20H25N5O8 (463.1703)

Asp Ser Asn Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]pentanedioic acid

C16H25N5O11 (463.155)

Asp Ser Gln Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]butanedioic acid

C16H25N5O11 (463.155)

Asp Ser Trp Gly

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C20H25N5O8 (463.1703)

Asp Thr Asp Asn

(3S)-3-[(2S,3R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxybutanamido]-3-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}propanoic acid

C16H25N5O11 (463.155)

Asp Thr Asn Asp

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxybutanamido]-3-carbamoylpropanamido]butanedioic acid

C16H25N5O11 (463.155)

Asp Trp Gly Ser

(3S)-3-amino-3-{[(1S)-1-[({[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}methyl)carbamoyl]-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C20H25N5O8 (463.1703)

Asp Trp Ser Gly

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-hydroxyethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C20H25N5O8 (463.1703)

Glu Asp Asn Ser

(4S)-4-amino-4-{[(1S)-1-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}ethyl]carbamoyl}-2-carboxyethyl]carbamoyl}butanoic acid

C16H25N5O11 (463.155)

Glu Asp Ser Asn

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}-2-carboxyethyl]carbamoyl}butanoic acid

C16H25N5O11 (463.155)

Glu Asn Asp Ser

(4S)-4-amino-4-{[(1S)-2-carbamoyl-1-{[(1S)-2-carboxy-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}ethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C16H25N5O11 (463.155)

Glu Asn Ser Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]butanedioic acid

C16H25N5O11 (463.155)

Glu Ser Asp Asn

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-carboxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}butanoic acid

C16H25N5O11 (463.155)

Glu Ser Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]butanedioic acid

C16H25N5O11 (463.155)

Gly Asp Ser Trp

(3S)-3-(2-aminoacetamido)-3-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C20H25N5O8 (463.1703)

Gly Asp Trp Ser

(3S)-3-(2-aminoacetamido)-3-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C20H25N5O8 (463.1703)

Gly Ser Asp Trp

(3S)-3-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C20H25N5O8 (463.1703)

Gly Ser Trp Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-(1H-indol-3-yl)propanamido]butanedioic acid

C20H25N5O8 (463.1703)

Gly Trp Asp Ser

(3S)-3-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C20H25N5O8 (463.1703)

Gly Trp Ser Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-hydroxypropanamido]butanedioic acid

C20H25N5O8 (463.1703)

Met Cys Asn Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S2 (463.1559)

Met Cys Pro Asn

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C17H29N5O6S2 (463.1559)

Met Asn Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S2 (463.1559)

Met Asn Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C17H29N5O6S2 (463.1559)

Met Pro Cys Asn

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C17H29N5O6S2 (463.1559)

Met Pro Asn Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C17H29N5O6S2 (463.1559)

Asn Cys Met Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S2 (463.1559)

Asn Cys Pro Met

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid

C17H29N5O6S2 (463.1559)

Asn Asp Asp Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-3-carboxypropanamido]-3-hydroxybutanoic acid

C16H25N5O11 (463.155)

Asn Asp Glu Ser

(4S)-4-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-4-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}butanoic acid

C16H25N5O11 (463.155)

Asn Asp Ser Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-3-hydroxypropanamido]pentanedioic acid

C16H25N5O11 (463.155)

Asn Asp Thr Asp

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-3-hydroxybutanamido]butanedioic acid

C16H25N5O11 (463.155)

Asn Glu Asp Ser

(4S)-4-[(2S)-2-amino-3-carbamoylpropanamido]-4-{[(1S)-2-carboxy-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C16H25N5O11 (463.155)

Asn Glu Ser Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carboxybutanamido]-3-hydroxypropanamido]butanedioic acid

C16H25N5O11 (463.155)

Asn Met Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S2 (463.1559)

Asn Met Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C17H29N5O6S2 (463.1559)

Asn Pro Cys Met

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C17H29N5O6S2 (463.1559)

Asn Pro Met Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C17H29N5O6S2 (463.1559)

Asn Ser Asp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-carboxypropanamido]pentanedioic acid

C16H25N5O11 (463.155)

Asn Ser Glu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-4-carboxybutanamido]butanedioic acid

C16H25N5O11 (463.155)

Asn Thr Asp Asp

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-carboxypropanamido]butanedioic acid

C16H25N5O11 (463.155)

Pro Cys Met Asn

(2S)-3-carbamoyl-2-[(2S)-4-(methylsulfanyl)-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]butanamido]propanoic acid

C17H29N5O6S2 (463.1559)

Pro Cys Asn Met

(2S)-2-[(2S)-3-carbamoyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]-4-(methylsulfanyl)butanoic acid

C17H29N5O6S2 (463.1559)

Pro Met Cys Asn

(2S)-3-carbamoyl-2-[(2R)-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-sulfanylpropanamido]propanoic acid

C17H29N5O6S2 (463.1559)

Pro Met Asn Cys

(2R)-2-[(2S)-3-carbamoyl-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]-3-sulfanylpropanoic acid

C17H29N5O6S2 (463.1559)

Pro Asn Cys Met

(2S)-2-[(2R)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C17H29N5O6S2 (463.1559)

Pro Asn Met Cys

(2R)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C17H29N5O6S2 (463.1559)

Gln Asp Asp Ser

(3S)-3-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carboxypropanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C16H25N5O11 (463.155)

Gln Asp Ser Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carboxypropanamido]-3-hydroxypropanamido]butanedioic acid

C16H25N5O11 (463.155)

Gln Ser Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-carboxypropanamido]butanedioic acid

C16H25N5O11 (463.155)

Ser Asp Asp Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carboxypropanamido]-3-carboxypropanamido]-4-carbamoylbutanoic acid

C16H25N5O11 (463.155)

Ser Asp Glu Asn

(4S)-4-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carboxypropanamido]-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}butanoic acid

C16H25N5O11 (463.155)

Ser Asp Gly Trp

(3S)-3-[(2S)-2-amino-3-hydroxypropanamido]-3-[({[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C20H25N5O8 (463.1703)

Ser Asp Asn Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carboxypropanamido]-3-carbamoylpropanamido]pentanedioic acid

C16H25N5O11 (463.155)

Ser Asp Gln Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carboxypropanamido]-4-carbamoylbutanamido]butanedioic acid

C16H25N5O11 (463.155)

Ser Asp Trp Gly

(3S)-3-[(2S)-2-amino-3-hydroxypropanamido]-3-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C20H25N5O8 (463.1703)

Ser Glu Asp Asn

(4S)-4-[(2S)-2-amino-3-hydroxypropanamido]-4-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-carboxyethyl]carbamoyl}butanoic acid

C16H25N5O11 (463.155)

Ser Glu Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carboxybutanamido]-3-carbamoylpropanamido]butanedioic acid

C16H25N5O11 (463.155)

Ser Gly Asp Trp

(3S)-3-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C20H25N5O8 (463.1703)

Ser Gly Trp Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-(1H-indol-3-yl)propanamido]butanedioic acid

C20H25N5O8 (463.1703)

Ser Asn Asp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-carboxypropanamido]pentanedioic acid

C16H25N5O11 (463.155)

Ser Asn Glu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-4-carboxybutanamido]butanedioic acid

C16H25N5O11 (463.155)

Ser Gln Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-carboxypropanamido]butanedioic acid

C16H25N5O11 (463.155)

Ser Trp Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-indol-3-yl)propanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C20H25N5O8 (463.1703)

Ser Trp Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-indol-3-yl)propanamido]acetamido}butanedioic acid

C20H25N5O8 (463.1703)

Thr Asp Asp Asn

(3S)-3-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-carboxyethyl]carbamoyl}propanoic acid

C16H25N5O11 (463.155)

Thr Asn Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-carboxypropanamido]butanedioic acid

C16H25N5O11 (463.155)

Trp Asp Gly Ser

(3S)-3-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-[({[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C20H25N5O8 (463.1703)

Trp Asp Ser Gly

(3S)-3-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-hydroxyethyl]carbamoyl}propanoic acid

C20H25N5O8 (463.1703)

Trp Gly Asp Ser

(3S)-3-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C20H25N5O8 (463.1703)

Trp Gly Ser Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-hydroxypropanamido]butanedioic acid

C20H25N5O8 (463.1703)

Trp Ser Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-hydroxypropanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C20H25N5O8 (463.1703)

Trp Ser Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-hydroxypropanamido]acetamido}butanedioic acid

C20H25N5O8 (463.1703)

4-[(5-Amino-1-methyl-1H-indol-3-yl)methyl]-3-methoxy-N-[(2-methylphenyl)sulfonyl]benzamide

4-[(5-amino-1-methyl-1H-indol-3-yl)methyl]-3-methoxy-N-[(2-methylphenyl)sulfonyl]-Benzamide

C25H25N3O4S (463.1566)

YO-01027

C26H23F2N3O3 (463.1707)

2-ethoxyethyl [2-[(2-chloro-4-nitrophenyl)azo]-5-(diethylamino)phenyl]carbamate

C21H26ClN5O5 (463.1622)

N-(6-Methoxy-3-pyridinyl)-1,2-dimethyl-N-{[5-(2-methylphenyl)-2-p yridinyl]methyl}-1H-imidazole-4-sulfonamide

C24H25N5O3S (463.1678)

Rosuvastatin Lactone

C22H26FN3O5S (463.1577)

Pelitrexol

C20H25N5O6S (463.1525)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2692 - Glycinamide Ribonucleotide Formyltransferase Inhibitor

Berzosertib

C24H25N5O3S (463.1678)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

ent-Rosuvastatin Lactone

C22H26FN3O5S (463.1577)

(E)-3-[9-methyl-2-(4-methylpiperazin-1-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]-2-(4-methylphenyl)sulfonylprop-2-enenitrile

C24H25N5O3S (463.1678)

N-(1,3-benzodioxol-5-ylmethyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-4-ylethyl]-2,2,2-trifluoroacetamide

C23H24F3N3O4 (463.1719)

3-[2-[1-(4-methoxyphenyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl]spiro[6,7-dihydro-5H-1-benzothiophene-4,5-imidazolidine]-2,4-dione

C25H25N3O4S (463.1566)

(6R,7S,8S)-N-(4-fluorophenyl)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C26H23F2N3O3 (463.1707)

(6S,7S,8R)-N-(4-fluorophenyl)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C26H23F2N3O3 (463.1707)

(6R,7S,8R)-N-(4-fluorophenyl)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C26H23F2N3O3 (463.1707)

(6R,7R,8S)-N-(4-fluorophenyl)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C26H23F2N3O3 (463.1707)

(6R,7R,8R)-N-(4-fluorophenyl)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C26H23F2N3O3 (463.1707)

(6S,7R,8R)-N-(4-fluorophenyl)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C26H23F2N3O3 (463.1707)

(6S,7R,8S)-N-(4-fluorophenyl)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C26H23F2N3O3 (463.1707)

(6S,7S,8S)-N-(4-fluorophenyl)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C26H23F2N3O3 (463.1707)

N-(3-chloro-4-fluorophenyl)-6-[3-(4-hydroxymorpholin-4-ium-4-yl)propoxy]-7-methoxyquinazolin-4-amine

C22H25ClFN4O4+ (463.1548)

ST 21:6;O4;Tau

C23H29NO7S (463.1665)

ERK1/2 inhibitor 7

C23H22FN7OS (463.159)

ERK1/2 inhibitor 7 is a potent ERK inhibitor with an IC50 of 0.94 nM for ERK2 (WO2021110168A1, WX006)[1].

MGL-IN-1

C24H22FN5O4 (463.1656)

MGL-IN-1 is a potent and selective irreversible MGL (β-lactam-based monoacylglycerol lipase) inhibitor. MGL-IN-1 alleviates symptoms in a MS model in vivo and exhibits analgesic effects in an acute inflammatory pain model in vivo. MGL-IN-1 displays high membrane permeability and brain penetrant[1].

1,6,8-trihydroxy-5-[5-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]-3-methyltetraphene-7,12-dione

C26H25NO7 (463.1631)